Big Four
EY pulls out as BioPharma auditor due to conflict of interest
BioPharma revealed its board is now proposing that the company's previous auditor, PricewaterhouseCoopers (PwC), be appointed for one further year
BioPharma Credit has revealed that ‘Big Four’ firm EY has decided to withdraw from its proposed role as auditor at the firm after discovering a conflict of interest due to tax work carried out by its U.S. offices.
You'll need to
subscribe to unlock this content. Already subscribed? Login?
